Jill Carlton

Dr. Jill Carlton

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2008 in Health Technology Assessment
Verified
Journal Article
Open access
PDF file
JCJill Carlton
Jill Carlton
JKJ Karnon
J Karnon
CCC Czoski-Murray
C Czoski-Murray
KSK Smith
K Smith
JMJ Marr
J Marr
Health Technology Assessment Volume: 12, Issue: 25, Published in June 2008

1 November 2005 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
MEMireia Espallargues
Mireia Espallargues
CCCarolyn J. Czoski-Murray
Carolyn J. Czoski-Murray
NBNicholas J. Bansback
Nicholas J. Bansback
JCJill Carlton
Jill Carlton
GLGrace M. Lewis
Grace M. Lewis
JBJohn Brazier
John Brazier
Purpose. To estimate health status utility values in patients with age-related macular degeneration (ARMD) associated with visual impairments, by using preference-based measures of health.

28 January 2011 in Eye
Verified
Journal Article
Closed access
JCJill Carlton
Jill Carlton
EKE Kaltenthaler
E Kaltenthaler

13 January 2020 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
JCJill Carlton
Jill Carlton
TPTessa Peasgood
Tessa Peasgood
SKS. Khan
S. Khan
RBR. Barber
R. Barber
JBJ. Bostock
J. Bostock
AKA. D. Keetharuth
A. D. Keetharuth
Patient-reported outcome measures (PROMs) are widely used in the United Kingdom (UK) and internationally to report and monitor patients’ subjective assessments of their symptoms and functional status and also their quality of life. Whilst the importance of involving the public in PROM development to increase the quality of the developed PROM has been highlighted this practice is not widespread. There is a lack of guidance on how public involvement (PI) could be embedded in the development of PROMs, where the roles can be more complex than in other types of research. This paper provides a timely review and sets out an emerging framework for fully incorporating PI into PROM development.

1 July 2009 in Value in Health
Verified
Journal Article
Closed access
CCCarolyn Czoski-Murray
Carolyn Czoski-Murray
JCJill Carlton
Jill Carlton
JBJohn Brazier
John Brazier
TYTracey Young
Tracey Young
NPNatalie L. Papo
Natalie L. Papo
HKHyong Kwon Kang
Hyong Kwon Kang

5 March 2015 in Journal of Medical Screening
Verified
Journal Article
Open access
FSFrea Sloot
Frea Sloot
HHHans Lj Hoeve
Hans Lj Hoeve
MKMarlou LA de Kroon
Marlou LA de Kroon
AGAndré Goedegebure
André Goedegebure
JCJill Carlton
Jill Carlton
FGfor the EUS€REEN study group
for the EUS€REEN study group
Objective: To examine the diversity in paediatric vision and hearing screening programmes in Europe. Methods: Themes for comparison of screening programmes derived from literature were used to compile three questionnaires on vision, hearing, and public health screening. Tests used, professions involved, age, and frequency of testing seem to influence sensitivity, specificity, and costs most. Questionnaires were sent to ophthalmologists, orthoptists, otolaryngologists, and audiologists involved in paediatric screening in all EU full-member, candidate, and associate states. Answers were cross-checked. Results: Thirty-nine countries participated; 35 have a vision screening programme, 33 a nation-wide neonatal hearing screening programme. Visual acuity (VA) is measured in 35 countries, in 71% of these more than once. First measurement of VA varies from three to seven years of age, but is usually before age five. At age three and four, picture charts, including Lea Hyvarinen, are used most; in children over four, Tumbling-E and Snellen. As first hearing screening test, otoacoustic emission is used most in healthy neonates, and auditory brainstem response in premature newborns. The majority of hearing testing programmes are staged; children are referred after 1–4 abnormal tests. Vision screening is performed mostly by paediatricians, ophthalmologists, or nurses. Funding is mostly by health insurance or state. Coverage was reported as >95% in half of countries, but reporting was often not first-hand. Conclusion: Largest differences were found in VA charts used (12), professions involved in vision screening (10), number of hearing screening tests before referral (1–4), and funding sources (8).